Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03447639 · ClinicalTrials.gov registry record · Phase 4
Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
A Phase 4 study, sponsored by Corewell Health East.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT03447639: Clinical Trial Phase 4 study, sponsored by Corewell Health East.
NCT03447639 is a Phase 4 study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03447639, a Phase 4 study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
Over the last decade, there has been great emphasis on reducing the incidence of hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will evaluate the effectiveness of Betadine irrigation solution (2% povidone-iodine) instilled into the bladder immediately prior to indwelling catheter removal to decrease the risk of subsequent bacteriuria, leading to decreased rates of NHSN defined CAUTI.
Primary Outcome
Per NHSN defined catheter associated UTI (CAUTI) criteria
Interventions
- DRUG Povidone-iodine irrigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-03-29 |
| Est. Completion | 2018-10-22 |
| Phase | Phase 4 |
Why NCT03447639 stopped before completion
NCT03447639 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Povidone-iodine irrigation is the first listed.
NCT03447639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03447639 about?
NCT03447639 is a clinical study titled "Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal". Over the last decade, there has been great emphasis on reducing the incidence of hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will evaluate the effectiveness of Betadine irrigation solution (2% povidone-iodine) instilled into the bladder immediately prior to in...
What is the current status of trial NCT03447639?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2018-03-29. Estimated completion is 2018-10-22.
What interventions are being tested in trial NCT03447639?
The interventions under investigation include: Povidone-iodine irrigation (DRUG).
Who is sponsoring clinical trial NCT03447639?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03447639's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI